Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
gallium-68-dotatate (netspot) (1 trial)
in111-octreoscan (1 trial)
Intestinal Neoplasms (Phase 2)
Neuroendocrine Tumors (Phase 2)
Pancreatic Neoplasms (Phase 2)
Stomach Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (2 total)